Retinoid

Oct 04, 2019

Galderma Receives FDA Approval for AKLIEF® (trifarotene) Cream, 0.005%, the First New Retinoid Molecule for the Treatment of Acne in Over 20 Years

Feb 28, 2019

Galderma Announces Publication of Pivotal Phase 3 PERFECT 1 and PERFECT 2 Clinical Trials of Trifarotene in Patients with Moderate Facial and Truncal Acne in the Journal of the American Academy of Dermatology

Nov 15, 2018

Acne Drugs Market Size Worth $5.9 Billion By 2025 | CAGR: 4.2%: Grand View Research, Inc.

Jul 27, 2018

Acne Medication Market Expected to Reach $10,929 Million by 2025 | CAGR 3.9% - Allied Market Research

Oct 19, 2017

AOBiome Therapeutics Reports Positive Efficacy Results from Phase 2b Clinical Trial of Ammonia Oxidizing Bacteria (AOB) for the Treatment of Acne Vulgaris

Sep 20, 2017

AOBiome Expands Intellectual Property Estate, Announces Issuance of U.S. Patent for Ammonia Oxidizing Bacteria (AOB) for the Treatment of Acne

May 31, 2017

Global Acne Treatment Market is Expected to Reach US$ 7,348 Mn by 2025 - Persistence Market Research